相关实验视频
Updated: Sep 11, 2025

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
2.9K
改变RNA剪接作为1型肌肉性缩症 (DM1) 临床试验的替代终点
J Andrew Berglund1, Aaron Novack2, Iva Ivanovska Holder2
1The RNA Institute, University at Albany, SUNY, Albany, NY, USA.
Journal of neuromuscular diseases
|August 14, 2025
概括
肌性缩症1型 (DM1) 是一种进展性遗传疾病,影响多个器官系统. 拼接变化显示出作为替代终点的承诺,以加速新的DM1治疗方法的临床试验.
科学领域:
- 遗传学和分子生物学
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 肌性衰变1型 (DM1) 是一种渐进的,多系统性遗传疾病,由DMPK基因的重复扩展突变引起.
- 异常的mRNA前拼接,称为拼接病,是DM1的标志,在器官系统中驱动各种临床表现.
- 目前,没有疾病修饰的治疗方法存在于DM1,临床试验的设计是复杂的疾病异质性.
研究的目的:
- 探索拼接变化的潜力,作为加速DM1临床试验的替代终点.
- 验证使用复合拼接指数来预测DM1患者的功能益处.
- 评估结节病纠正与DM1中有意义的临床结果之间的相关性.
主要方法:
- 利用DM1患者的自然史数据来分析拼接失调和肌肉功能之间的相关性.
- 开发和评估基于错误拼接事件的复合拼接指数.
- 在临床试验的背景下,研究拼接变化与功能益处之间的关系.
主要成果:
- 自然史数据表明,在DM1中,失调的拼接和肌肉功能受损之间存在强烈的相关性.
- 一个复合拼接指数被确定为一个潜在的有用的替代终点来预测未来的功能益处.
- 错误拼接的外子的程度与肌肉盲样 (MBNL) RNA结合蛋白的活性相关.
结论:
- 拼接变化,特别是复合拼接指数,是DM1临床试验的有希望的替代终点.
- 这些替代终点可能有助于加速开发DM1治疗方法.
- 需要进一步的研究来证实基于拼接的代用终点的有效性及其与临床结果的相关性.
相关概念视频
Alternative RNA Splicing
21.7K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.7K
RNA Splicing
57.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
57.0K
Pre-mRNA Processing: RNA Splicing
5.4K
5.4K
Nonsense-mediated mRNA Decay
10.8K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.8K

